SEP 16, 2020 12:20 PM EST

Genomics: A programmatic approach to bringing Genomics in-house

Speaker

Abstract

Factors we considered when bringing NGS to our in-house lab and holistic benefits to patient outcomes​.

Norton Healthcare has integrated genomics testing into multiple aspects of patient care for several years. During this time, utilization of this service has grown exponentially causing delays in being able to review this information timely as part of a patient’s overall plan of care. As a result of delays and the increased positive response by providers in utilization of genomics testing, a team was brought together to create a program around in-house genomics testing.

In 2019, the decision was made to bring genomics testing in-house. This decision was made to help decrease delays in testing, increase utilization of this testing, the ability to integrate this type of testing in more areas and the desire to create state of the art programs across our system.

Operationally, bringing genomics testing in house is a multifaceted ask requiring involvement from many different areas, timelines and a structured approach. The steps we took involved grant funding applications, vendor reviews, vendor selection, contract review/negotiations/amendments/execution, and internal planning on logistics, operational buildout, technology integration, and full program creation.


Show Resources
You May Also Like
SEP 17, 2021 12:00 PM CST
C.E. CREDITS
SEP 17, 2021 12:00 PM CST
Date: September 16, 2021 Time: 9:00pm (PDT), 12:00am (EDT) 3D cellular models like organoids and spheroids offer an opportunity to better understand complex biology in a physiologically rele...
SEP 14, 2021 7:00 AM PDT
C.E. CREDITS
SEP 14, 2021 7:00 AM PDT
Date: September 14, 2021 Time: 7am PDT, 10am EDT, 4pm CEST A conventional thermal cycler has long been a commodity product in the lab and end-point PCR techniques can be completed almost wit...
DEC 01, 2021 7:00 AM PST
C.E. CREDITS
DEC 01, 2021 7:00 AM PST
Date: December 01, 2021 Time: 7:00am (PST), 10:00am (EST) In the era of immuno-oncology, there is a growing need for the identification of new biomarkers predictive for sensitivity to anti-P...
SEP 16, 2021 8:00 AM PDT
C.E. CREDITS
SEP 16, 2021 8:00 AM PDT
Date: September 16, 2021 Time: 8:00am (PDT), 11:00am (EDT) Rapid screening and speed of scale-up in protein therapeutics are critical factors in today’s biotech and pharma workflows. T...
DEC 07, 2021 10:00 AM PST
C.E. CREDITS
DEC 07, 2021 10:00 AM PST
Date: December 07, 2021 Time: 10:00am (PST) The RNAscope™ technology allows high sensitivity and spatial resolution providing pivotal single-cell information to gain better insights in...
JUN 24, 2021 8:00 AM PDT
C.E. CREDITS
JUN 24, 2021 8:00 AM PDT
Date: June 24, 2021 Time: 8:00am (PDT), 11:00am (EDT) Cardiovascular disease is a leading health problem, affecting almost 30% of individuals in the developed world, and comprises a wide ran...
Loading Comments...
Show Resources